oxytocin has been researched along with Airway-Obstruction* in 2 studies
1 trial(s) available for oxytocin and Airway-Obstruction
Article | Year |
---|---|
The effect of oxytocin on contractility of the equine oesophagus: a potential treatment for oesophageal obstruction.
This study was performed to determine the effect of administration of i.v. oxytocin on the contractility of the musculature associated with the equine oesophagus. Nine clinically normal horses were fitted with a nasogastric tube modified with inflatable latex cuffs. These cuffs were connected to piezoelectric pressure recording devices. Oxytocin in 3 different doses or saline controls were administered i.v. in a randomised block pattern. Systolic blood pressure, ECG, heart rate and nasogastric tube cuff pressures were then measured for 60 min. Administration of oxytocin i.v. at 0.11 and 0.22 iu/kg bwt, resulted in a short-term statistically significant relaxation of the musculature of the equine oesophagus. When oxytocin was administered at 0.11, 0.22 and 0.44 iu/kg bwt, no clinically significant cardiovascular changes were seen. In approximately 5% of the oxytocin administrations, signs of mild short-term abdominal discomfort were observed. In clinical cases of noncomplicated oesophageal obstruction, it is suggested that reduction in tone of oesophageal musculature may result in passage of oesophageal obstructions with reduced risk of oesophageal injury when compared to other traditional treatments. Topics: Airway Obstruction; Animals; Blood Pressure; Electrocardiography; Esophagus; Female; Heart; Heart Rate; Horse Diseases; Horses; Injections, Intravenous; Male; Muscle Contraction; Oxytocin | 2000 |
1 other study(ies) available for oxytocin and Airway-Obstruction
Article | Year |
---|---|
[Two cases of congenital airway obstruction managed with ex utero intrapartum treatment procedures: anesthetic implications].
An ex utero intrapartum treatment (EXIT) procedure provides sufficient time to gain control of the potentially obstructed fetal upper airway while uterine placental circulation is maintained during cesarean section. We report 2 cases in which fetal congenital upper airway obstruction was managed without complications during EXIT procedures. We also discuss general considerations concerning the obstetric patient and the performance of intramuscular fetal anesthesia. Before the hysterotomy, sevoflurane at 1.5 minimum alveolar concentration was administered to assure sufficient uterine relaxation during EXIT. The 2 parturients remained hemodynamically stable during the procedure and uterine and placental perfusion was adequate. Nasotracheal intubation was possible in 1 fetus after a cervical mass was dissected. In the other, a tracheostomy was created. After the umbilical cord was clamped, the concentration of sevoflurane anesthetic gas was reduced and oxytocin and methylergometrine were administered to induce adequate uterine contractions within a few minutes. Both neonates survived the EXIT procedure with no complications. Topics: Adult; Airway Obstruction; Anesthesia, Inhalation; Anesthesia, Obstetrical; Anesthetics, Inhalation; Cesarean Section; Female; Head and Neck Neoplasms; Humans; Hysterotomy; Infant, Newborn; Intubation, Intratracheal; Methyl Ethers; Methylergonovine; Oropharyngeal Neoplasms; Oxytocin; Placental Circulation; Polyhydramnios; Pregnancy; Sevoflurane; Teratoma; Tracheostomy; Uterine Contraction | 2007 |